In order to determine the impact of DLGAP1-AS1 on glioma progression, we transfected shRNAs targeting DLGAP1-AS1 (sh-DLGAP1-AS1-1 and sh-DLGAP1-AS1-2) into LN229 and U87 cells. The gene discussed is DLGAP1; the disease is central nervous system cancer.